FREE SEMINAR
Annual SDARTs Conference 2019

Annual SDARTs Conference 2019

Annual Conference of The San Diego Academy

Dr. Ramon Llull and Dr. Chris Rogers

Dr. Rogers met and collaborated with thought leaders in the Annual Conference of The San Diego Academy of Regenerative Therapies (SDARTs) from August 2-4 in San Diego, CA. The annual SDARTs conference together pioneers and experts in regenerative medicine and offers training on many different applications of regenerative medicine across different medical specialty fields. At San Diego Orthobiolgoics Medical Group, we continue to learn innovative procedures to find the best treatment options for our patients!

Clinical Trial Announced: Knee Osteoarthritis

Clinical Trial Announced: Knee Osteoarthritis

Dr. Christopher Rogers and Dr. Mary Ambach are proud to announce that San Diego Orthobiologics Medical Group is leading a multi-center clinical trial for the treatment of knee osteoarthritis. Click for details. https://personalizedstemcells.com

 

FDA Approved Clinical Trial on Stem Cell Derived from Patient’s Own Fat to Treat Knee Arthritis Will Be Conducted at San Diego Orthobiologics Medical Group!

FDA Approved Clinical Trial on Stem Cell Derived from Patient’s Own Fat to Treat Knee Arthritis Will Be Conducted at San Diego Orthobiologics Medical Group!

Dr. Christopher Rogers and Dr. Mary Ambach from the San Diego Orthobiologics Medical Group are one of only 10 sites treating patients in a multi-center clinical trial for the treatment of knee osteoarthritis using a patient’s own fat-derived stem cells.  Personalized Stem Cells, Inc is sponsoring the FDA approved clinical trial, which is the FIRST EVER in the United States to study the use of a patient’s own fat-derived stem cells processed and tested in a centralized FDA inspected manufacturing lab.   In addition to treating knee osteoarthritis, the patient’s stem cells may be stored in this facility and potentially used for the treatment of other medical conditions in future approved clinical trials.

Information about the clinical trial can be found here.

Check for updates regarding the study and the recruitment process on our website, SDOMG.com

 

DataBiologics launched their world-wide Regenerative Medicine Registry at the Orthobiologics Institute (TOBI) annual conference in Chicago last week.

DataBiologics launched their world-wide Regenerative Medicine Registry at the Orthobiologics Institute (TOBI) annual conference in Chicago last week.

DataBiologics launched their world-wide Regenerative Medicine Registry at the Orthobiologics Institute (TOBI) annual conference in Chicago last week.

Founders Dr. Christopher Rogers, Dr. Gerald Malanga and Dr. Jay Bowen attended the conference and were excited to see the huge interest in collecting patient reported outcome.

DataBiologics is simple to use, practical and affordable which allows Regenerative Medicine physicians to track their patient outcomes and collaborate with other physicians from around the world.

Dr. Chris Rogers and Dr. Gerald Malanga, co-founders of DataBiologics met with Dr. Arnold Caplan (middle) at TOBI last week. Dr. Caplan was the first scientist to discover, characterize and name the Mesenchymal Stem Cell in 1991. All doctors agree that now is the time to collect meaningful data, so that we can advance the field of Regenerative Medicine.
The Orthobiologic Institute (TOBI) founder, Dr. Steven Sampson shares a glass of champagne with DataBiologics co-founders, Dr. Jay Bowen, Dr. Gerald Malanga and Dr. Chris Rogers.

DataBiologics made its debut last week at the TOBI annual conference in Chicago. Physicians who join the Orthohealing Method Network will also receive access to the DataBiologics Registry.

Executive Director, Linda Rivord-Gutierrez and Patricia Rogers were on hand at TOBI last week to share all the exciting news about the new DataBiologics Registry.
Dr Rogers and Dr Ambach at the Largest PRP and Regenerative Medicine Symposium

Dr Rogers and Dr Ambach at the Largest PRP and Regenerative Medicine Symposium

The Orthobiologic Institute (TOBI) is the most widely recognized regenerative symposium and is attended by hundreds of physicians and specialists from all over the world. Dr Rogers and Dr Ambach were presenters and faculty to the 10th annual TOBI symposium in Chicago where cutting edge research and latest evidence on PRP and stem cell treatments were presented and discussed.

Pin It on Pinterest